For the quarter ending 2026-03-31, ATOS has $37,943K in assets. $7,457K in debts. $31,718K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 31,718 | 41,299 | 51,845 | 57,857 |
| Restricted cash | 110 | 110 | 110 | 110 |
| Prepaid materials | 3,013 | 3,081 | 3,143 | 3,475 |
| Prepaid expenses and other current assets | 1,827 | 1,128 | 580 | 1,075 |
| Total current assets | 36,668 | 45,618 | 55,678 | 62,517 |
| Other assets | 1,275 | 1,990 | 2,334 | 1,998 |
| Total assets | 37,943 | 47,608 | 58,012 | 64,515 |
| Accounts payable | 2,569 | 4,293 | 3,536 | 2,010 |
| Accrued expenses | 2,807 | 1,307 | 1,989 | 2,200 |
| Payroll liabilities | 943 | 1,558 | 1,125 | 1,054 |
| Other current liabilities | 1,138 | 1,097 | 1,575 | 1,556 |
| Total current liabilities | 7,457 | 8,255 | 8,225 | 6,820 |
| Total liabilities | 7,457 | 8,255 | 8,225 | 6,820 |
| Common stock - 0.18 par value 350,000,000 shares authorized 8,611,361 shares issued and outstanding as of march 31, 2026 and december 31, 2025 | 1,550 | 1,550 | 23,488 | 23,488 |
| Additional paid-in capital | 286,562 | 285,840 | 263,399 | 262,615 |
| Treasury stock, at cost 88,003 shares of common stock at march 31, 2026 and december 31, 2025 | 1,475 | 1,475 | 1,475 | 1,475 |
| Accumulated deficit | -256,151 | -246,562 | -235,625 | -226,933 |
| Total stockholders' equity | 30,486 | 39,353 | 49,787 | 57,695 |
| Total liabilities and stockholders' equity | 37,943 | 47,608 | 58,012 | 64,515 |
ATOSSA THERAPEUTICS, INC. (ATOS)
ATOSSA THERAPEUTICS, INC. (ATOS)